WallStreetZenWallStreetZen

NASDAQ: BRTX
Biorestorative Therapies Inc Earnings & Revenue

BRTX past revenue growth

How has BRTX's revenue growth performed historically?
Company
21.7%
Industry
78.66%
Market
18.83%
BRTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BRTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BRTX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BRTX earnings and revenue history

Current Revenue
$145.8k
Current Earnings
-$14.4M
Current Profit Margin
-9,887.2%

BRTX Return on Equity

Current Company
-114.7%
Current Industry
-63.5%
Current Market
188%
BRTX's Return on Equity (-114.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BRTX announces earnings.

BRTX Return on Assets

Current Company
-107.2%
Current Industry
2.9%
BRTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BRTX Return on Capital Employed

Current Company
-124.83%
Current Industry
19.5%
BRTX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BRTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BRTX$145.80k-$14.16M-$14.42M+5.61%N/A
OGEN$20.63k-$20.21M-$20.26M-55.04%N/A
ADXN$1.83M-$11.01M-$11.73M-22.11%N/A
NTBL$311.00k-$11.19M-$12.22M-13.47%N/A
CHRO$0.00-$7.88M-$8.98MN/AN/A

Biorestorative Therapies Earnings & Revenue FAQ

What were BRTX's earnings last quarter?

On Invalid Date, Biorestorative Therapies (NASDAQ: BRTX) reported Q4 2023 earnings per share (EPS) of -$0.57, up 51.69% year over year. Total Biorestorative Therapies earnings for the quarter were -$2.83 million. In the same quarter last year, Biorestorative Therapies's earnings per share (EPS) was -$1.18.

If you're new to stock investing, here's how to buy Biorestorative Therapies stock.

What was BRTX's earnings growth in the past year?

As of Q2 2024, Biorestorative Therapies's earnings has grown year over year. Biorestorative Therapies's earnings in the past year totalled -$14.42 million.

What was BRTX's revenue last quarter?

On Invalid Date, Biorestorative Therapies (NASDAQ: BRTX) reported Q4 2023 revenue of $19.30 thousand up 421.62% year over year. In the same quarter last year, Biorestorative Therapies's revenue was $3.70 thousand.

What was BRTX's revenue growth in the past year?

As of Q2 2024, Biorestorative Therapies's revenue has grown 21.7% year over year. This is 56.95 percentage points lower than the US Biotechnology industry revenue growth rate of 78.66%. Biorestorative Therapies's revenue in the past year totalled $145.80 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.